Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Acta Ophthalmologica|March 5, 2013
Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathyClaus Zehetner, Rudolf Kirchmair, Martina Kralinger, et al.Journal of Cataract and Refractive Surgery|February 22, 2023
Potential environmental effect of reducing the variation of disposable materials used for cataract surgeryNicolas Winklmair, Gerhard Kieselbach, Julian Bopp, et al.Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 4, 2018
Triamcinolone in small-gauge vitrectomy for epiretinal membrane peelingReinhard Angermann, Claus Zehetner, Patrick Sidoroff, et al.Investigative Ophthalmology & Visual Science|October 3, 2002
Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administrationMonika Voigt, Martina Kralinger, Gerhard Kieselbach, et al.Acta Medica Austriaca|March 8, 2005
[Diagnosis, therapy and follow-up of diabetic eye diseases]Michael Stur, Stefan Egger, Anton Haas, et al.Peptides|December 2, 2004
Secretoneurin in the human aqueous humor and the absence of an effect of frequently used eye drops on the levelsKatrin Stemberger, Julia Pallhuber, Alfred Doblinger, et al.Regulatory Peptides|February 9, 2010
Secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retinaBarbara Teuchner, Andreas Dimmer, Josef Troger, et al.Wiener Klinische Wochenschrift|December 20, 2012
[Diagnosis, therapy and follow up of diabetic eye disease]Michael Stur, Stefan Egger, Anton Haas, et al.Brain Research Reviews|July 29, 2006
Peptidergic nerves in the eye, their source and potential pathophysiological relevanceJosef Troger, Gerhard Kieselbach, Barbara Teuchner, et al.Peptides|June 14, 2008
Substance P and secretoneurin in vitreous aspirates of patients with various vitreoretinal diseasesKatrin Lorenz, Josef Troger, Reiner Fischer-Colbrie, et al.Pageof 2